MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Satellos Bioscience Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026
$6.44−0.02 (-0.31%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Satellos Bioscience statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Market Cap | $99.56M | $166.30M |
| Enterprise Value | $89.75M | $88.19M |
Income (trailing twelve months)
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Operating Income | -$26.46M | -$21.40M |
| Pretax Income | -$24.70M | -$14.34M |
| EBITDA | -$26.46M | -$16.91M |
| EPS (Diluted) | -$1.70 | -$0.83 |
Returns
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -95.2% | -38.1% |
Balance sheet
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.80M | $61.43M |
| Net Cash (Debt) | $9.80M | $15.35M |
| Net Cash Per Share | $0.63 | $0.66 |
| Working Capital | $27.78M | $76.81M |
Financial position
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Current Ratio | 7.77 | 3.34 |
| Quick Ratio | 2.39 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Operating Cash Flow | -$23.60M | -$12.35M |
| Capital Expenditures | -$6.00K | -$1.08M |
| Free Cash Flow | -$23.60M | -$20.22M |
| FCF Per Share | -$1.53 | -$0.42 |
Dividends and yields
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| FCF Yield | -23.7% | -8.72% |
Shares
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Shares Outstanding | 15,458,900 | 58,127,000 |
| Shares Change (YoY) | 52.6% | 10.9% |
| Float | 15,458,900 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
| Shares Held by Institutions | 49.7% | 59.4% |
Taxes
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Income Tax | $172.00K | $79.87K |
Scores
| Measure | Satellos Bioscience | Industry median |
|---|---|---|
| Altman Z-Score | 9.26 | -0.22 |
Calculated by StockData from Satellos Bioscience's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.